REWIND: Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: A post-hoc analysis from the randomized trial
European Journal of Heart Failure
KRH Branch, GR Dagenais, A Avezum, J Basile, I Conget, WC Cushman, P Jansky, M Lakshmanan, F Lanas, LA Leiter, P Pais, N Pogosova, PJ Raubenheimer, L Ryden, JE Shaw, WHH Sheu, T Temelkova-Kurktschiev, MA Bethel, HC Gerstein, R Chinthanie, JL Probstfield
September 2022